- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 16/32 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products from oncogenes
Patent holdings for IPC class C07K 16/32
Total number of patents in this class: 3469
10-year publication summary
|
192
|
297
|
402
|
339
|
353
|
367
|
391
|
377
|
317
|
105
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Genentech, Inc. | 3742 |
149 |
| Hoffmann-La Roche Inc. | 3060 |
99 |
| F. Hoffmann-La Roche AG | 7958 |
84 |
| Amgen Inc. | 3779 |
43 |
| Mayo Foundation for Medical Education and Research | 2981 |
42 |
| Merus N.V. | 185 |
41 |
| Zymeworks Inc. | 234 |
40 |
| Genmab A/S | 382 |
40 |
| Daiichi Sankyo Company, Limited | 1829 |
39 |
| The Trustees of the University of Pennsylvania | 4122 |
38 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
34 |
| Novartis AG | 11238 |
28 |
| Centre National de La Recherche Scientifique | 9632 |
28 |
| Memorial Sloan-Kettering Cancer Center | 1789 |
28 |
| Sanofi | 3836 |
28 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
27 |
| Sutro Biopharma, Inc. | 148 |
27 |
| Xencor, Inc. | 403 |
26 |
| Immatics Biotechnologies GmbH | 1144 |
25 |
| Dragonfly Therapeutics, Inc. | 136 |
25 |
| Other owners | 2578 |